Stockscreener 앱 받기
0.8533
1.14%
-0.0127
전일 마감가:
$0.866
열려 있는:
$0.8757
하루 거래량:
837.64K
Relative Volume:
0.08
시가총액:
$83.73M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-12.03%
1개월 성능:
+10.44%
6개월 성능:
-76.22%
1년 성능:
-71.84%
1일 변동 폭
$0.8531
$0.88
1주일 범위
$0.856
$1.02
52주 변동 폭
$0.6816
$7.2904
Atyr Pharma Inc Stock (ATYR) Company Profile
명칭
Atyr Pharma Inc
전화
(858) 731-8389
주소
10240 SORRENTO VALLEY ROAD, SAN DIEGO
ATYR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATYR
Atyr Pharma Inc
|
0.8546 | 84.86M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.65 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
638.50 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
443.80 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.69 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.38 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Atyr Pharma Inc Stock (ATYR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-16 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-09-15 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2025-09-15 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-09-15 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-09-15 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-02-18 | 개시 | Leerink Partners | Outperform |
| 2025-01-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-10-04 | 개시 | Wells Fargo | Overweight |
| 2024-09-05 | 개시 | Jefferies | Buy |
| 2023-07-05 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-10-12 | 개시 | RBC Capital Mkts | Outperform |
| 2021-09-21 | 개시 | Piper Sandler | Overweight |
| 2021-05-10 | 개시 | Laidlaw | Buy |
| 2020-08-17 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-03-04 | 개시 | ROTH Capital | Buy |
| 2020-03-02 | 개시 | Oppenheimer | Outperform |
| 2018-02-14 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2017-09-07 | 개시 | Piper Jaffray | Overweight |
| 2016-12-13 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2015-12-16 | 개시 | Citigroup | Neutral |
| 2015-06-01 | 개시 | Citigroup | Buy |
| 2015-06-01 | 개시 | JP Morgan | Overweight |
모두보기
Atyr Pharma Inc 주식(ATYR)의 최신 뉴스
The Gross Law Firm Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineATYR - MarketScreener
aTyr Pharma, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsATYR - Lelezard
Class Action Lawsuit Filed: aTyr Pharma, Inc. (ATYR)Join by December 8, 2025Contact Levi & Korsinsky - Stockhouse
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
ATYR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that aTyr Pharma, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel ... - Bluefield Daily Telegraph
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages aTyr Pharma, - GlobeNewswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - Newsfile
Is aTyr Pharma Inc. stock cheap at current valuation2025 Winners & Losers & Precise Trade Entry Recommendations - newser.com
What catalysts could drive aTyr Pharma Inc. stock higherMarket Sentiment Summary & Reliable Entry Point Alerts - newser.com
Real time breakdown of aTyr Pharma Inc. stock performance2025 Valuation Update & Fast Exit/Entry Strategy Plans - newser.com
Is aTyr Pharma Inc. stock poised for growthGDP Growth & Weekly Market Pulse Alerts - newser.com
aTyr Pharma Inc. stock prediction for this weekGDP Growth & Verified High Yield Trade Plans - newser.com
Lost Money on aTyr Pharma, Inc. (ATYR)? Contact Levi & Korsinsky to Join Class Action Before December 8, 2025 - ACCESS Newswire
December 8, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ATYR - Bluefield Daily Telegraph
Levi & Korsinsky Notifies aTyr Pharma, Inc. (ATYR) InvestorsLead Plaintiff Deadline on December 8, 2025 - Stockhouse
ATYR Shareholder Alert: New aTyr Pharma, Inc. (ATYR) - GlobeNewswire
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire Inc.
ATYR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - Newsfile
aTyr Pharma (ATYR) to Release Earnings on Thursday - MarketBeat
Relative strength of aTyr Pharma Inc. in sector analysisWeekly Trend Recap & Reliable Intraday Trade Plans - newser.com
What earnings revisions data tells us about aTyr Pharma Inc.July 2025 Breakouts & Fast Entry Momentum Alerts - newser.com
Will aTyr Pharma Inc. (471A) stock outperform benchmarksInsider Selling & Weekly Chart Analysis and Guides - newser.com
How aTyr Pharma Inc. (471A) stock reacts to stronger dollarPortfolio Gains Summary & Daily Growth Stock Investment Tips - newser.com
ROSEN, LEADING INVESTOR COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel ... - Bluefield Daily Telegraph
ROSEN, LEADING INVESTOR COUNSEL, Encourages aTyr Pharma, - GlobeNewswire
The Gross Law Firm Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming ... - Caledonian Record
The Gross Law Firm Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – ATYR - GlobeNewswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in aTyr Pharma, Inc. of Class Action Lawsuit and Upcoming DeadlinesATYR - FinancialContent
Portnoy Law Firm Announces Class Action on Behalf of aTyr Pharma, Inc. Investors - GlobeNewswire
ATYR Shareholder Alert: New aTyr Pharma, Inc. (ATYR) Securities Class Filed; Class Period Significantly Enlarged — Hagens Berman - Morningstar
Why aTyr Pharma Inc. stock could see breakout soonWeekly Investment Report & Entry Point Confirmation Signals - newser.com
Ranking aTyr Pharma Inc. among high performing stocks via toolsJuly 2025 Outlook & Short-Term High Return Strategies - newser.com
Is aTyr Pharma Inc. stock a defensive play in 2025Weekly Trend Summary & Comprehensive Market Scan Insights - newser.com
Burned by aTyr Pharma, Inc.? Contact Levi & Korsinsky to SueWallSt and Fight Back - ACCESS Newswire
aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Does aTyr Pharma Inc. show high probability of reboundPortfolio Gains Summary & Advanced Technical Analysis Signals - newser.com
Lawsuit filed for Investors who lost money with shares of aTyr Pharma, Inc. (NASDAQ: ATYR) - openPR.com
aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Have Opportu - GuruFocus
Investors who lost money on aTyr Pharma, Inc.(ATYR) should contact Levi & Korsinsky about ... - Bluefield Daily Telegraph
Investors who lost money on aTyr Pharma, Inc.(ATYR) should - GlobeNewswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - MarketScreener
Statistical indicators supporting aTyr Pharma Inc.’s strengthProfit Target & Fast Moving Trade Plans - newser.com
Will aTyr Pharma Inc. stock go up soonRate Cut & Verified Momentum Watchlists - newser.com
How aTyr Pharma Inc. stock responds to policy changesJuly 2025 Closing Moves & Weekly Market Pulse Updates - fcp.pa.gov.br
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in aTyr ... - Black Hills Pioneer
Will aTyr Pharma Inc. stock benefit from upcoming earnings reports2025 Market Overview & Fast Gain Stock Trading Tips - fcp.pa.gov.br
ROSEN, LEADING INVESTOR COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Class Action Reminder: ATYR Investors Should Contact Robbins LLP for Information About Leading the aTyr Pharma, Inc. Class Action Lawsuit - Barchart.com
Atyr Pharma Inc (ATYR) 재무 분석
Atyr Pharma Inc (ATYR)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Atyr Pharma Inc 주식 (ATYR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| SCHIMMEL PAUL | Director |
Oct 09 '25 |
Buy |
0.94 |
317,999 |
299,364 |
1,413,023 |
| Gross Jane A | Director |
Mar 17 '25 |
Buy |
4.00 |
3,750 |
15,000 |
9,750 |
| Broadfoot Jill Marie | Chief Financial Officer |
Feb 04 '25 |
Sale |
3.78 |
1,254 |
4,740 |
31,763 |
| DENYES NANCY | General Counsel |
Feb 04 '25 |
Sale |
3.78 |
899 |
3,398 |
26,555 |
0.03%
0.32%
자본화:
|
볼륨(24시간):